Pancrelipase

Pancrelipase
Pancrelipase
Clinical data
AHFS/Drugs.com monograph
MedlinePlus a604035
Pregnancy cat.  ?
Legal status  ?
Routes Oral
Identifiers
CAS number 53608-75-6 YesY
ATC code A09AA02
DrugBank DB00085
UNII FQ3DRG0N5K YesY
Chemical data
Formula C5850H8902N1606O1739S49 
Mol. mass 131 kDa
 N(what is this?)  (verify)

Pancrelipase is a form of enzyme therapy for the treatment of various digestive disorders, primarily exocrine pancreatic insufficiency. It is a mixture of three digestive enzymes, amylase, trypsin, and lipase, which are normally produced by the pancreas. Pancrelipase is a form of pancreatin having a elevated content of lipase.

Contents

Use

Pancrelipase is used by patients suffering from cystic fibrosis, chronic pancreatitis and after pancreatectomy.

Brand names for Pancrelipase include Creon, Pancrease, Ultrase, Mezym and Ozym.

Creon

Creon is a Pancrelipase manufactured and produce by Abbott Laboratories. Its available in different packaging ie Creon 5, 10 or 20.

Creon 10,000 mini-microspeheres (delayed release capsules) is available in China, Singapore, Malaysia and Thailand with enzyme contains lipase 10,000 u, amylase 8,000 u, protease 600 u.[1]

Its main indication is for patients with pancretic exocrine insufficiency ie, cystic fibrosis, chronic pancreatitis, pancreatectomy, pancreatic cancer and gastrotectomy.

References

External links